Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Overview of Blood Vessels01:14

Overview of Blood Vessels

The human cardiovascular system comprises five primary types of blood vessels: arteries, arterioles, veins, venules, and capillaries, each serving unique functions.
Arteries and Arterioles: Arteries are muscular and elastic vessels that primarily carry oxygenated blood from the heart to body tissues, except for the pulmonary artery, which carries deoxygenated blood. They have thick walls to withstand high pressure and contain a layer of muscle tissue, allowing them to expand or contract as...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias].

Wiener klinische Wochenschrift·2026
Same author

Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Prognostic impact of spread through air spaces (STAS) in mucin-producing lung adenocarcinoma: a multinational cohort study.

Cancer treatment and research communications·2026
Same author

Removal of pulp tissue remnants from the isthmus area of lower molars using Shock Wave Enhanced Emission Photo-acoustic Streaming and sonic-activated irrigation.

Photodiagnosis and photodynamic therapy·2026
Same author

Update on Pleural Epithelioid Mesothelioma: New Insights for Diagnosis and Patient Management.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 10, 2026

Characterization of Blood Outgrowth Endothelial Cells (BOEC) from Porcine Peripheral Blood
08:02

Characterization of Blood Outgrowth Endothelial Cells (BOEC) from Porcine Peripheral Blood

Published on: January 6, 2022

BPC 157 and blood vessels.

Sven Seiwerth, Luka Brcic, Lovorka Batelja Vuletic

  • 1Institute of Pathology, University of Zagreb, School of Medicine, Salata 10, 1000 Zagreb, Croatia. seiwerth@mef.hr.

Current Pharmaceutical Design
|June 21, 2013
PubMed
Summary

The peptide BPC 157 optimizes blood vessel repair by modulating pathways like nitric oxide (NO) and vascular endothelial growth factor (VEGF). This potent angiomodulatory agent enhances healing after various vascular injuries.

More Related Videos

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
10:15

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits

Published on: August 20, 2014

Related Experiment Videos

Last Updated: May 10, 2026

Characterization of Blood Outgrowth Endothelial Cells (BOEC) from Porcine Peripheral Blood
08:02

Characterization of Blood Outgrowth Endothelial Cells (BOEC) from Porcine Peripheral Blood

Published on: January 6, 2022

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
10:15

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits

Published on: August 20, 2014

Area of Science:

  • Biomedical science
  • Vascular biology
  • Regenerative medicine

Background:

  • Blood vessel integrity is crucial for healing and disease.
  • Vascular responses to injury involve complex processes like clotting and edema.
  • Tumor biology heavily relies on pathological vascularization.

Purpose of the Study:

  • To review the effects of BPC 157 on blood vessels post-injury.
  • To elucidate BPC 157's role in vascular healing mechanisms.
  • To investigate BPC 157's impact on angiogenesis, vasculogenesis, and arteriogenesis.

Main Methods:

  • Review of existing literature on BPC 157 and vascular responses.
  • Analysis of BPC 157's effects on endothelium damage, clotting, and edema.
  • Investigation of BPC 157's influence on vasoactive pathways (NO, VEGF, FAK).

Main Results:

  • BPC 157 demonstrated potent angiomodulatory effects.
  • It optimized vascular response and subsequent healing processes.
  • BPC 157 influences NO, VEGF, and FAK pathways.

Conclusions:

  • BPC 157 is a highly effective agent for optimizing vascular repair.
  • Its mechanisms involve modulating key vasoactive pathways.
  • BPC 157 shows promise in improving healing outcomes after vascular damage.